vs
Amarin Corp plc（AMRN）与花花公子（PLBY）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是花花公子的1.3倍（$45.1M vs $34.9M），花花公子净利率更高（10.3% vs -23.3%，领先33.6%），Amarin Corp plc同比增速更快（7.0% vs 4.2%），过去两年花花公子的营收复合增速更高（11.0% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
花花公子集团（Playboy, Inc.）起源于1953年由休·海夫纳联合合伙人在美国芝加哥创立，初始部分资金来自海夫纳母亲提供的1000美元贷款，是美国知名生活方式与娱乐内容品牌，旗下核心《花花公子》杂志同时发行电子版与纸质版。
AMRN vs PLBY — 直观对比
营收规模更大
AMRN
是对方的1.3倍
$34.9M
营收增速更快
AMRN
高出2.8%
4.2%
净利率更高
PLBY
高出33.6%
-23.3%
两年增速更快
PLBY
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $34.9M |
| 净利润 | $-10.5M | $3.6M |
| 毛利率 | — | 73.3% |
| 营业利润率 | 35.5% | 7.9% |
| 净利率 | -23.3% | 10.3% |
| 营收同比 | 7.0% | 4.2% |
| 净利润同比 | 33.0% | 128.6% |
| 每股收益（稀释后） | — | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNPLBY
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $34.9M | ||
| Q3 25 | $49.7M | $29.0M | ||
| Q2 25 | $72.7M | $28.1M | ||
| Q1 25 | $42.0M | $28.9M | ||
| Q4 24 | $62.3M | $33.5M | ||
| Q3 24 | $42.3M | $29.4M | ||
| Q2 24 | $67.5M | $24.9M |
净利润AMRNPLBY
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $3.6M | ||
| Q3 25 | $-7.7M | $460.0K | ||
| Q2 25 | $-14.1M | $-7.7M | ||
| Q1 25 | $-15.7M | $-9.0M | ||
| Q4 24 | $-48.6M | $-12.5M | ||
| Q3 24 | $-25.1M | $-33.8M | ||
| Q2 24 | $1.5M | $-16.7M |
毛利率AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 73.3% | ||
| Q3 25 | 44.7% | 76.0% | ||
| Q2 25 | 69.2% | 65.4% | ||
| Q1 25 | 59.8% | 68.6% | ||
| Q4 24 | -15.4% | 70.8% | ||
| Q3 24 | 38.5% | 61.0% | ||
| Q2 24 | 63.4% | 67.8% |
营业利润率AMRNPLBY
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 7.9% | ||
| Q3 25 | -22.4% | 4.7% | ||
| Q2 25 | -22.0% | -20.9% | ||
| Q1 25 | -39.9% | -21.7% | ||
| Q4 24 | -84.3% | -13.3% | ||
| Q3 24 | -59.5% | -96.0% | ||
| Q2 24 | -0.8% | -37.0% |
净利率AMRNPLBY
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 10.3% | ||
| Q3 25 | -15.6% | 1.6% | ||
| Q2 25 | -19.4% | -27.3% | ||
| Q1 25 | -37.4% | -31.3% | ||
| Q4 24 | -78.0% | -37.4% | ||
| Q3 24 | -59.4% | -114.7% | ||
| Q2 24 | 2.3% | -66.9% |
每股收益（稀释后）AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.05 | ||
| Q3 25 | $-0.02 | $0.00 | ||
| Q2 25 | $-0.03 | $-0.08 | ||
| Q1 25 | $-0.04 | $-0.10 | ||
| Q4 24 | $-0.12 | $-0.13 | ||
| Q3 24 | $-0.06 | $-0.45 | ||
| Q2 24 | $0.00 | $-0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $37.8M |
| 总债务越低越好 | — | $174.2M |
| 股东权益账面价值 | — | $18.4M |
| 总资产 | $645.8M | $292.4M |
| 负债/权益比越低杠杆越低 | — | 9.48× |
8季度趋势，按日历期对齐
现金及短期投资AMRNPLBY
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $37.8M | ||
| Q3 25 | $286.6M | $27.5M | ||
| Q2 25 | $298.7M | $19.6M | ||
| Q1 25 | $281.8M | $23.7M | ||
| Q4 24 | $294.2M | $30.9M | ||
| Q3 24 | $305.7M | $9.5M | ||
| Q2 24 | $306.7M | $16.9M |
总债务AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | — | $174.2M | ||
| Q3 25 | — | $176.8M | ||
| Q2 25 | — | $177.5M | ||
| Q1 25 | — | $176.3M | ||
| Q4 24 | — | $176.6M | ||
| Q3 24 | — | $200.0M | ||
| Q2 24 | — | $196.3M |
股东权益AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $18.4M | ||
| Q3 25 | $458.9M | $3.8M | ||
| Q2 25 | $464.9M | $-17.5M | ||
| Q1 25 | $473.7M | $-11.4M | ||
| Q4 24 | $486.2M | $-7.7M | ||
| Q3 24 | $531.4M | $-15.7M | ||
| Q2 24 | $551.9M | $15.7M |
总资产AMRNPLBY
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $292.4M | ||
| Q3 25 | $659.8M | $278.3M | ||
| Q2 25 | $670.1M | $264.1M | ||
| Q1 25 | $655.7M | $270.6M | ||
| Q4 24 | $685.3M | $284.7M | ||
| Q3 24 | $750.6M | $271.5M | ||
| Q2 24 | $799.9M | $301.8M |
负债/权益比AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | — | 9.48× | ||
| Q3 25 | — | 46.86× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $1.4M |
| 自由现金流经营现金流 - 资本支出 | — | $1.1M |
| 自由现金流率自由现金流/营收 | — | 3.2% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.39× |
| 过去12个月自由现金流最近4个季度 | — | $-1.0M |
8季度趋势，按日历期对齐
经营现金流AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $1.4M | ||
| Q3 25 | $-12.7M | $10.1M | ||
| Q2 25 | $16.6M | $-3.9M | ||
| Q1 25 | $-12.5M | $-7.6M | ||
| Q4 24 | $-13.3M | $161.0K | ||
| Q3 24 | $-2.4M | $-6.5M | ||
| Q2 24 | $-2.7M | $-3.0M |
自由现金流AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | — | $-4.3M | ||
| Q1 25 | — | $-7.7M | ||
| Q4 24 | — | $-401.0K | ||
| Q3 24 | — | $-7.0M | ||
| Q2 24 | — | $-3.7M |
自由现金流率AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 33.8% | ||
| Q2 25 | — | -15.2% | ||
| Q1 25 | — | -26.5% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | — | -23.7% | ||
| Q2 24 | — | -14.8% |
资本支出强度AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.6% |
现金转化率AMRNPLBY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 22.02× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
PLBY
| Transferred At Point In Time | $22.2M | 64% |
| Trademark Licensing | $6.5M | 19% |
| Related Party | $5.0M | 14% |
| Other | $1.1M | 3% |
